← All trials
NCT05093296
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2021
- Primary completion
- Apr 1, 2024
- Completion date
- Sep 1, 2024
- First posted
- Oct 26, 2021
- Last posted
- Nov 4, 2021
- Enrollment
- 62
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of HeidelbergLead sponsor
- University of HeidelbergStudy director
- German Federal Ministry of Education and ResearchCollaborator
- Heidelberg UniversityCollaborator
- Heidelberg UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.